CN1063415A - 缓解绝经期症状的组合物的制备方法 - Google Patents

缓解绝经期症状的组合物的制备方法 Download PDF

Info

Publication number
CN1063415A
CN1063415A CN91100408A CN91100408A CN1063415A CN 1063415 A CN1063415 A CN 1063415A CN 91100408 A CN91100408 A CN 91100408A CN 91100408 A CN91100408 A CN 91100408A CN 1063415 A CN1063415 A CN 1063415A
Authority
CN
China
Prior art keywords
melatonin
estrogen
compositions
daily dose
compatibility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN91100408A
Other languages
English (en)
Chinese (zh)
Inventor
迈克尔·科恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Medical Research Ltd
Original Assignee
Applied Medical Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/297,328 external-priority patent/US4945103A/en
Application filed by Applied Medical Research Ltd filed Critical Applied Medical Research Ltd
Priority to CN91100408A priority Critical patent/CN1063415A/zh
Publication of CN1063415A publication Critical patent/CN1063415A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Fats And Perfumes (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
CN91100408A 1989-01-17 1991-01-24 缓解绝经期症状的组合物的制备方法 Pending CN1063415A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN91100408A CN1063415A (zh) 1989-01-17 1991-01-24 缓解绝经期症状的组合物的制备方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/297,328 US4945103A (en) 1989-01-17 1989-01-17 Method of treating pre-menstrual syndrome
CA002100086A CA2100086C (en) 1989-01-17 1991-01-10 Compositions and methods for alleviating menopausal symptoms
PCT/US1991/000235 WO1992011855A1 (en) 1989-01-17 1991-01-10 Compositions and methods for alleviating menopausal symptoms
CN91100408A CN1063415A (zh) 1989-01-17 1991-01-24 缓解绝经期症状的组合物的制备方法

Publications (1)

Publication Number Publication Date
CN1063415A true CN1063415A (zh) 1992-08-12

Family

ID=27169496

Family Applications (1)

Application Number Title Priority Date Filing Date
CN91100408A Pending CN1063415A (zh) 1989-01-17 1991-01-24 缓解绝经期症状的组合物的制备方法

Country Status (19)

Country Link
EP (1) EP0566566B1 (enrdf_load_stackoverflow)
JP (1) JPH06506908A (enrdf_load_stackoverflow)
CN (1) CN1063415A (enrdf_load_stackoverflow)
AT (1) ATE131059T1 (enrdf_load_stackoverflow)
AU (1) AU667456B2 (enrdf_load_stackoverflow)
CA (1) CA2100086C (enrdf_load_stackoverflow)
DD (1) DD297768A5 (enrdf_load_stackoverflow)
DE (1) DE69115294T2 (enrdf_load_stackoverflow)
DK (1) DK0566566T3 (enrdf_load_stackoverflow)
ES (1) ES2081470T3 (enrdf_load_stackoverflow)
FI (1) FI933172L (enrdf_load_stackoverflow)
GR (1) GR3018470T3 (enrdf_load_stackoverflow)
IN (1) IN170311B (enrdf_load_stackoverflow)
NO (1) NO932444L (enrdf_load_stackoverflow)
NZ (2) NZ232144A (enrdf_load_stackoverflow)
PH (1) PH26649A (enrdf_load_stackoverflow)
PT (1) PT92866B (enrdf_load_stackoverflow)
WO (1) WO1992011855A1 (enrdf_load_stackoverflow)
ZA (2) ZA90300B (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1853272A1 (en) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
US9446049B2 (en) * 2006-03-09 2016-09-20 Jonathan V. Wright Hormone replacement formulation
US20180050019A1 (en) * 2015-03-06 2018-02-22 Repoceuticals Aps Melatonin for Preventing and Treating Radiation Vaginitis and Proctitis
RU2723764C1 (ru) * 2019-06-14 2020-06-17 Елена Николаевна Усольцева Способ прогнозирования эффективности лечения климактерического синдрома мелатонином у женщин в перименопаузе и постменопаузе

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855305A (en) * 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin

Also Published As

Publication number Publication date
PT92866B (pt) 1995-12-29
NO932444L (no) 1993-08-24
FI933172A0 (fi) 1993-07-12
FI933172A7 (fi) 1993-08-10
NZ236755A (en) 1994-09-27
AU7181291A (en) 1992-08-17
CA2100086C (en) 2003-09-30
DE69115294T2 (de) 1996-05-02
PH26649A (en) 1992-09-04
NO932444D0 (no) 1993-07-05
EP0566566B1 (en) 1995-12-06
ATE131059T1 (de) 1995-12-15
CA2100086A1 (en) 1992-07-11
PT92866A (pt) 1990-07-31
NZ232144A (en) 1997-05-26
AU667456B2 (en) 1996-03-28
DK0566566T3 (da) 1996-04-22
EP0566566A1 (en) 1993-10-27
WO1992011855A1 (en) 1992-07-23
ZA90300B (en) 1990-11-28
IN170311B (enrdf_load_stackoverflow) 1992-03-14
ES2081470T3 (es) 1996-03-16
JPH06506908A (ja) 1994-08-04
FI933172L (fi) 1993-08-10
GR3018470T3 (en) 1996-03-31
DD297768A5 (de) 1992-01-23
DE69115294D1 (de) 1996-01-18
ZA91303B (en) 1992-01-29

Similar Documents

Publication Publication Date Title
EP0354921B1 (en) Use of melatonin for the manufacture of a contraceptive composition
CZ288062B6 (cs) Přípravek pro ženskou antikoncepci
EP1589976B1 (en) Use of a combination of an aromatase inhibitor, a progestin and an oestrogen for the treatment of endometriosis
CN1063415A (zh) 缓解绝经期症状的组合物的制备方法
AU5968390A (en) Compositions useful as contraceptives in males
EP1007052A1 (en) Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
EP0472628A1 (en) Use of melatonin derivatives for effecting contraception
IL96926A (en) Pharmaceutical compositions for alleviating post-menopausal symptoms comprising melatonin and a least one estrogen and/ or androgen
AU644367B2 (en) Use of melatonin derivatives for effecting contraception
EP1522306A1 (en) A pharmaceutical product for hormone replacement therapy comprising tibolone or a derivative thereof and estradiol or a derivative thereof
HK1082918B (en) Use of a combination of an aromatase inhibitor, a progestin and an oestrogen for the treatment of endometriosis
HK1113546A (en) Composition comprising a combination of an aromatase inhibitor, a progestin and an estrogen, and its use for the treatment of endometriosis
NZ244997A (en) Use of melatonin derivatives for contraception

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication